Annual Total Expenses
$7.18 B
-$3.81 B-34.68%
December 31, 2024
Summary
- As of February 20, 2025, MRNA annual total expenses is $7.18 billion, with the most recent change of -$3.81 billion (-34.68%) on December 31, 2024.
- During the last 3 years, MRNA annual total expenses has risen by +$2.74 billion (+61.73%).
- MRNA annual total expenses is now -34.68% below its all-time high of $10.99 billion, reached on December 31, 2023.
Performance
MRNA Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$2.21 B
+$287.00 M+14.91%
December 31, 2024
Summary
- As of February 20, 2025, MRNA quarterly total expenses is $2.21 billion, with the most recent change of +$287.00 million (+14.91%) on December 31, 2024.
- Over the past year, MRNA quarterly total expenses has dropped by -$595.00 million (-21.20%).
- MRNA quarterly total expenses is now -41.77% below its all-time high of $3.80 billion, reached on September 30, 2023.
Performance
MRNA Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
MRNA Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -34.7% | -21.2% |
| 3 y3 years | +61.7% | -21.2% |
| 5 y5 years | +1108.9% | -21.2% |
MRNA Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -34.7% | +61.7% | -41.8% | +54.4% |
| 5 y | 5-year | -34.7% | +1108.9% | -41.8% | +1538.5% |
| alltime | all time | -34.7% | >+9999.0% | -41.8% | >+9999.0% |
Moderna Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $7.18 B(-34.7%) | $2.21 B(+14.9%) |
| Sep 2024 | - | $1.93 B(+21.5%) |
| Jun 2024 | - | $1.58 B(+10.5%) |
| Mar 2024 | - | $1.43 B(-48.9%) |
| Dec 2023 | $10.99 B(+16.3%) | $2.81 B(-26.1%) |
| Sep 2023 | - | $3.80 B(+74.0%) |
| Jun 2023 | - | $2.18 B(-1.0%) |
| Mar 2023 | - | $2.20 B(-38.2%) |
| Dec 2022 | $9.46 B(+113.0%) | $3.57 B(+73.8%) |
| Sep 2022 | - | $2.05 B(-3.1%) |
| Jun 2022 | - | $2.12 B(+23.7%) |
| Mar 2022 | - | $1.71 B(+11.3%) |
| Dec 2021 | $4.44 B(+328.2%) | $1.54 B(+21.1%) |
| Sep 2021 | - | $1.27 B(+10.2%) |
| Jun 2021 | - | $1.15 B(+141.7%) |
| Mar 2021 | - | $477.00 M(-5.4%) |
| Dec 2020 | $1.04 B(+74.6%) | $504.00 M(+104.0%) |
| Sep 2020 | - | $247.00 M(+63.6%) |
| Jun 2020 | - | $151.00 M(+11.9%) |
| Mar 2020 | - | $135.00 M(-3.8%) |
| Dec 2019 | $594.00 M(+10.9%) | $140.40 M(-2.6%) |
| Sep 2019 | - | $144.10 M(-6.3%) |
| Jun 2019 | - | $153.74 M(-1.3%) |
| Mar 2019 | - | $155.76 M(-16.2%) |
| Dec 2018 | $535.78 M(+20.0%) | $185.85 M(+51.7%) |
| Sep 2018 | - | $122.48 M(-0.3%) |
| Jun 2018 | - | $122.85 M(+17.2%) |
| Mar 2018 | - | $104.86 M(-19.5%) |
| Dec 2017 | $446.33 M(+37.2%) | $130.24 M(>+9900.0%) |
| Sep 2017 | - | $1.04 M(+9.2%) |
| Jun 2017 | - | $948.90 K(-1.9%) |
| Mar 2017 | - | $967.30 K(+131.7%) |
| Dec 2016 | $325.31 M(+6867.4%) | - |
| Dec 2016 | - | $417.40 K(+327.2%) |
| Sep 2016 | - | $97.70 K(-23.9%) |
| Jun 2016 | - | $128.40 K(+12.4%) |
| Mar 2016 | - | $114.20 K(-86.1%) |
| Dec 2015 | $4.67 M(+16.1%) | $820.00 K(-26.3%) |
| Sep 2015 | - | $1.11 M(-21.8%) |
| Jun 2015 | - | $1.42 M(+8.1%) |
| Mar 2015 | - | $1.31 M(+11.5%) |
| Dec 2014 | $4.02 M(+62.1%) | $1.18 M(-26.6%) |
| Sep 2014 | - | $1.61 M(+139.5%) |
| Jun 2014 | - | $671.00 K(+19.2%) |
| Mar 2014 | - | $563.00 K(-42.4%) |
| Dec 2013 | $2.48 M(-76.2%) | $977.00 K(+44.5%) |
| Sep 2013 | - | $676.00 K(+34.9%) |
| Jun 2013 | - | $501.00 K(+53.7%) |
| Mar 2013 | - | $326.00 K(-87.5%) |
| Dec 2012 | $10.42 M(-47.4%) | $2.61 M(+93.0%) |
| Sep 2012 | - | $1.35 M(-38.2%) |
| Jun 2012 | - | $2.19 M(-48.9%) |
| Mar 2012 | - | $4.28 M(+1.2%) |
| Dec 2011 | $19.81 M(-30.4%) | $4.23 M(-12.1%) |
| Sep 2011 | - | $4.81 M(-12.9%) |
| Jun 2011 | - | $5.52 M(+5.1%) |
| Mar 2011 | - | $5.25 M(+10.2%) |
| Dec 2010 | $28.46 M(+14.0%) | $4.76 M(-58.4%) |
| Sep 2010 | - | $11.46 M(+88.3%) |
| Jun 2010 | - | $6.08 M(-1.2%) |
| Mar 2010 | - | $6.16 M(+14.9%) |
| Dec 2009 | $24.97 M | $5.36 M(-21.2%) |
| Sep 2009 | - | $6.80 M(+3.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2009 | - | $6.59 M(+5.9%) |
| Mar 2009 | - | $6.22 M(-49.1%) |
| Dec 2008 | $53.29 M(-26.7%) | $12.24 M(+20.2%) |
| Sep 2008 | - | $10.18 M(-32.0%) |
| Jun 2008 | - | $14.98 M(-5.7%) |
| Mar 2008 | - | $15.89 M(-15.0%) |
| Dec 2007 | $72.67 M(+25.7%) | $18.70 M(-0.9%) |
| Sep 2007 | - | $18.86 M(+5.5%) |
| Jun 2007 | - | $17.89 M(+3.9%) |
| Mar 2007 | - | $17.22 M(+8.2%) |
| Dec 2006 | $57.81 M(+40.1%) | $15.91 M(+14.1%) |
| Sep 2006 | - | $13.94 M(+11.0%) |
| Jun 2006 | - | $12.56 M(-18.3%) |
| Mar 2006 | - | $15.39 M(+42.7%) |
| Dec 2005 | $41.25 M(+36.0%) | $10.78 M(+3.0%) |
| Sep 2005 | - | $10.46 M(+1.7%) |
| Jun 2005 | - | $10.29 M(+5.9%) |
| Mar 2005 | - | $9.72 M(+31.8%) |
| Dec 2004 | $30.34 M(+18.3%) | $7.37 M(-4.6%) |
| Sep 2004 | - | $7.73 M(+3.3%) |
| Jun 2004 | - | $7.49 M(-3.4%) |
| Mar 2004 | - | $7.75 M(+13.3%) |
| Dec 2003 | $25.65 M(+17.1%) | $6.84 M(+1.5%) |
| Sep 2003 | - | $6.74 M(-2.6%) |
| Jun 2003 | - | $6.92 M(+34.4%) |
| Mar 2003 | - | $5.15 M(-24.9%) |
| Dec 2002 | $21.91 M(+80.2%) | $6.86 M(+25.5%) |
| Sep 2002 | - | $5.46 M(+4.9%) |
| Jun 2002 | - | $5.21 M(+18.7%) |
| Mar 2002 | - | $4.39 M(+28.4%) |
| Dec 2001 | $12.16 M(-16.0%) | $3.42 M(+26.3%) |
| Sep 2001 | - | $2.70 M(-7.3%) |
| Jun 2001 | - | $2.92 M(-6.5%) |
| Mar 2001 | - | $3.12 M(-37.3%) |
| Dec 2000 | $14.48 M(+3.4%) | $4.98 M(+65.5%) |
| Sep 2000 | - | $3.01 M(-6.9%) |
| Jun 2000 | - | $3.23 M(-0.8%) |
| Mar 2000 | - | $3.26 M(-34.9%) |
| Dec 1999 | $14.00 M(+33.3%) | $5.00 M(+66.7%) |
| Sep 1999 | - | $3.00 M(+7.1%) |
| Jun 1999 | - | $2.80 M(-26.3%) |
| Mar 1999 | - | $3.80 M(+5.6%) |
| Dec 1998 | $10.50 M(+4.0%) | $3.60 M(+50.0%) |
| Sep 1998 | - | $2.40 M(-20.0%) |
| Jun 1998 | - | $3.00 M(+30.4%) |
| Mar 1998 | - | $2.30 M(-34.3%) |
| Dec 1997 | $10.10 M(+320.8%) | $3.50 M(+29.6%) |
| Sep 1997 | - | $2.70 M(+12.5%) |
| Jun 1997 | - | $2.40 M(+60.0%) |
| Mar 1997 | - | $1.50 M(+36.4%) |
| Dec 1996 | $2.40 M(-40.0%) | - |
| Sep 1996 | - | $1.10 M(-8.3%) |
| Jun 1996 | $4.00 M(+33.3%) | $1.20 M(+33.3%) |
| Mar 1996 | - | $900.00 K(-10.0%) |
| Dec 1995 | - | $1.00 M(+11.1%) |
| Sep 1995 | - | $900.00 K(-10.0%) |
| Jun 1995 | $3.00 M(+57.9%) | $1.00 M(+42.9%) |
| Mar 1995 | - | $700.00 K(0.0%) |
| Dec 1994 | - | $700.00 K(+16.7%) |
| Sep 1994 | - | $600.00 K(0.0%) |
| Jun 1994 | $1.90 M | $600.00 K(0.0%) |
| Mar 1994 | - | $600.00 K(+100.0%) |
| Dec 1993 | - | $300.00 K(-25.0%) |
| Sep 1993 | - | $400.00 K |
FAQ
- What is Moderna annual total expenses?
- What is the all time high annual total expenses for Moderna?
- What is Moderna annual total expenses year-on-year change?
- What is Moderna quarterly total expenses?
- What is the all time high quarterly total expenses for Moderna?
- What is Moderna quarterly total expenses year-on-year change?
What is Moderna annual total expenses?
The current annual total expenses of MRNA is $7.18 B
What is the all time high annual total expenses for Moderna?
Moderna all-time high annual total expenses is $10.99 B
What is Moderna annual total expenses year-on-year change?
Over the past year, MRNA annual total expenses has changed by -$3.81 B (-34.68%)
What is Moderna quarterly total expenses?
The current quarterly total expenses of MRNA is $2.21 B
What is the all time high quarterly total expenses for Moderna?
Moderna all-time high quarterly total expenses is $3.80 B
What is Moderna quarterly total expenses year-on-year change?
Over the past year, MRNA quarterly total expenses has changed by -$595.00 M (-21.20%)